patent

FTC Slams Justice Dept. Filing In Qualcomm Antitrust Case

The Federal Trade Commission on Thursday highlighted an unusual split with the U.S. Department of Justice’s Antitrust Division in a California federal court filing that slammed the DOJ’s antitrust watchdogs for butting into the FTC’s case against Qualcomm over the chipmaker’s patent licensing practices…

Read this piece in its entirety at Law360.

Apple, Twitter, AT&T, Verizon Beat Voip-Pal Patent Suits

Communications company Voip-Pal.com Inc. lost a handful of lawsuits accusing tech giants Apple, Twitter, AT&T and Verizon of infringing a pair of call-routing patents when a California federal judge on Monday ruled Voip-Pal’s patents are too generalized and abstract to be valid…

Read this piece in its entirety at Law360.

Lyft Says Prof’s Patent For Ride-Hailing Concept Is Abstract

Lyft Inc. is looking to kill a patent suit by a retired professor who says he invented the concept underlying the ride-hailing business, telling a California federal court Monday that his patent only describes an abstract idea for running a taxi dispatch service using computers…

Read this piece in its entirety at Law360.

Apple Can’t Dodge Patent Suit Over ‘Home’ Button Functions

Apple Inc. will have to face a suit alleging the “home” button on certain iPhones and iPads infringes patents held by a Korean company, after a California federal judge on Friday shot down the Cupertino-based tech behemoth’s bid to have the case dismissed as baseless…

Read this piece in its entirety at Law360.

Qualcomm Fires Back At Apple Witness Tampering Claim

Qualcomm traded blows once again with Apple on Friday in a smartphone patent trial in California federal court, claiming an Apple lawyer made an “utterly baseless” accusation of witness tampering against the San Diego-based tech giant and its counsel from Quinn Emanuel…

Read this piece in its entirety at Law360.

Hospira Tells Fed. Circ. To Reverse Sedative Patent Loss

Hospira Inc. asked the Federal Circuit on Tuesday to uphold the validity of a patent for its sedation drug Precedex for the second time this year, arguing that an Illinois federal court hadn’t correctly analyzed the obviousness of a key claim when deciding to invalidate the patent…

Read this piece in its entirety at Law360.